Stockholders' Equity |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | Note 7: Stockholders’ Equity The Company has a stock-based compensation plan, the Amended and Restated 2015 Equity Incentive Plan (the “EIP”), pursuant to which it has granted incentive and nonstatutory stock options and restricted stock units. Additionally, the Company's Amended and Restated 2015 Employee Stock Purchase Plan (the “ESPP”) allows eligible employees to purchase shares of common stock at a discounted price through payroll deductions. Stock Options. Stock option activity for the six months ended July 31, 2026 was as follows:
The aggregate intrinsic value of vested options exercised during the six months ended July 31, 2026 and 2025 was $0.2 million and $0.4 million, respectively. During the six months ended July 31, 2026, the Company granted 40,500 stock options with a $5.89 per share weighted average fair value. During the three months ended July 31, 2026 and three and six months ended July 31, 2025, no stock options were granted. Restricted Stock Units. RSU activity for the six months ended July 31, 2026 was as follows:
Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company canceled and returned these shares to the Amended and Restated 2015 Plan, which became available under the plan terms for future issuance. Employee Stock Purchase Plan. During each of the six months ended July 31, 2026 and 2025, employees purchased 0.1 million and 0.2 million shares at a weighted-average price of $10.82 per share and $7.46 per share, respectively. Stock Repurchase Plan. In June 2024, our board of directors authorized a common stock repurchase plan. As of July 31, 2026, our board of directors had authorized an aggregate repurchase of up to $24.0 million of common stock under this plan with no termination date. The Company repurchased in the open market 0.1 million shares and 0.2 million shares of common stock for an aggregate amount of $2.5 million and $3.2 million for the three months ended July 31, 2026 and 2025, respectively, and 0.4 million shares and 0.4 million shares of common stock for an aggregate amount of $5.7 million and $5.4 million for the six months ended July 31, 2026 and 2025, respectively. As of July 31, 2026, the remaining authorized amount for repurchases under this plan was approximately $2.2 million. The purchase price for shares of common stock repurchased is reflected as a reduction to common stock and additional paid-in capital. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||